Artículos por temáticas

Psychiatry looks towards the future in neurodegenerative and neurodevelopmental disorders

Sachdev PS.

Curr Opin Psychiatry. 2013 May;26(3):237-8. doi: 10.1097/YCO.0b013e32835fd70e.

[Psychosocial interventions in dementia]

Kurz A.

Nervenarzt. 2013 Jan;84(1):93-103; quiz 104-5. doi: 10.1007/s00115-012-3655-x.

Immunological aspects and anti-amyloid strategy for Alzheimer's dementia

Liščić RM.

Arh Hig Rada Toksikol. 2013 Dec;64(4):603-8. doi: 10.2478/10004-1254-64-2013-2414.

Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms

Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S79-86. doi: 10.3233/JAD-2012-129003.

Applying the IWG research criteria in clinical practice: feasibility and ethical issues

Molinuevo JL, Rami L.

Med Clin North Am. 2013 May;97(3):477-84. doi: 10.1016/j.mcna.2012.12.018. Epub 2013 Feb 1.

Aspects of communication in Alzheimer's disease: clinical features and treatment options

Woodward M.

Int Psychogeriatr. 2013 Jun;25(6):877-85. doi: 10.1017/S1041610213000318. Epub 2013 Mar 25.

Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand

Kulkantrakorn K, Tanyakitpisal P, Towanabut S, Dejthevaporn C, Rangseekajee P, Pongpakdee S, Laptikultham S, Rodprasert K, Setthawatcharawanich S, Thinkhamrop B.

Psychogeriatrics. 2013 Mar;13(1):1-8. doi: 10.1111/j.1479-8301.2012.00403.x. Epub 2012 Feb 17.

Plasma proteomics for the identification of Alzheimer disease

Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.

Understanding placebo responses in Alzheimer's disease clinical trials from the literature meta-data and CAMD database

Ito K, Corrigan B, Romero K, Anziano R, Neville J, Stephenson D, Lalonde R.

J Alzheimers Dis. 2013;37(1):173-83. doi: 10.3233/JAD-130575.

Low dose, high dose, or no dose: better prescribing of cholinesterase inhibitors for Alzheimer's disease

Ritchie CW, Zhinchin G.

Int Psychogeriatr. 2013 Apr;25(4):511-5. doi: 10.1017/S1041610212002414.

A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations

Foster NL, Jagust WJ, Fox NC.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):1-3. doi: 10.1097/WAD.0b013e31828ab5d8.

Jak zlepsit adherenci k lekovemu rezimu u klinicky komplexnich polymorbidnich senioru?

Topinkova E.

Vnitr Lek. 2013 Sep;59(9):760-3.

Alzheimer's disease: connecting findings from graph theoretical studies of brain networks

Tijms BM, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F.

Neurobiol Aging. 2013 Aug;34(8):2023-36. doi: 10.1016/j.neurobiolaging.2013.02.020. Epub 2013 Mar 28.

A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease

Peters KR, Lynn Beattie B, Feldman HH, Illes J.

Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.

Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies

Lunnon K, Mill J.

Am J Med Genet B Neuropsychiatr Genet. 2013 Dec;162B(8):789-99. doi: 10.1002/ajmg.b.32201. Epub 2013 Sep 13.